This 313-page report contains 83 tables and provides analysis of the global therapeutic drug monitoring testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.
The report provides test volume and sales forecasts by country and market segment for the following assays:
This report is a unique worldwide market and technology assessment designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study provides five-year forecasts for major TDM assays; compares features of leading analyzers; and profiles key competitors.
The report provides test volume and sales forecasts by country and market segment for the following assays:
- Amikacin
- Carbamazepine
- Cyclosporin
- Digoxin
- Everolimus
- Gentamicin
- Levetiracetam
- Lithium
- Methotrexate
- NAPA/Procainamide
- Phenobarbital
- Phenytoin
- Quinidine
- Sirolimus
- Tacrolimus
- Theophylline
- Tobramycin
- Topirimate
- Valproic Acid
- Vancomycin
This report is a unique worldwide market and technology assessment designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study provides five-year forecasts for major TDM assays; compares features of leading analyzers; and profiles key competitors.